Regeneron Pharmaceuticals reported $1.79B in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Acceleron Pharma XLRN:US $ 91.6M 3.24M
Agenus AGEN:US $ 77.12M 24.04M
Agios Pharmaceuticals AGIO:US $ 89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 366.71M 2.89M
Amgen AMGN:US $ 5.7B 1.93B
Astellas Pharma 4503:JP 290.05B 41.99B
AstraZeneca AZN:LN 7.09B 1.67B
Biogen BIIB:US $ 2289.3M 569.2M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Bluebird Bio BLUE:US $ 248.31M 4.31M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Esperion Therapeutics ESPR:US $ 73.19M 17.61M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
Intercept Pharmaceuticals ICPT:US $ 95.82M 15.19M
IONIS PHARMACEUT IONS:US $ 207.35M 3.77M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Kyowa Hakko Kirin 4151:JP 69.22B 3.66B
Merk MRK:US $ 9905M 839M
Moderna Inc MRNA:US 1.29B 621M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Novartis NOVN:VX 9.82B 464M
Novartis NVS:US 9.82B 464M
Pfizer PFE:US $ 13063M 3998M
Puma Biotechnology PBYI:US $ 55.11M 23.09M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Seattle Genetics SGEN:US $ 478.08M 23.68M
Teva Pharmaceutical TEVA:IT 3.33B 220M
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M
United Therapeutics UTHR:US $ 226.6M 217.3M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
YTE INCY:US $ 564.87M 58.95M